Keyphrases
Enterovirus
100%
Rotavirus
50%
Virus-like
50%
Norovirus
50%
Insect Cells
50%
Plasmid
50%
Epidemic Potential
50%
Potential Challenges
50%
Structural Assessment
50%
Baculovirus Expression Vector System
40%
Rota
30%
Vaccine Development
22%
Epigallocatechin-3-gallate
20%
Virus
14%
Optimized Expression
10%
Safe Model
10%
Case Particle
10%
Virus Research
10%
Non-infectious
10%
Particle Production
10%
Expression Host
10%
Whole Process
10%
Process Production
10%
Vector Potential
10%
Cell Viability
10%
Expression Vector
10%
Intranasal Administration
10%
Inactivated Virus
10%
Vaccine Technology
8%
Enhanced Immunogenicity
5%
Chronic Cardiomyopathy
5%
Mucosal Vaccine
5%
Cross-linked Amino Acids
5%
Chronic Meningitis
5%
Mucosal Membrane
5%
Parenteral Route
5%
Inactivating Agent
5%
Immunology and Microbiology
Enterovirus
100%
Plasmid
50%
Norovirus
50%
Expression Vector
50%
Rotavirus
50%
Virus-Like Particle
50%
Insect Cell
50%
Baculoviridae
40%
Virus
23%
Poliomyelitis Virus
10%
Genetic Transfection
10%
Cell Viability
10%
Virus Inactivation
10%
Mucosal Immune Response
10%
Serotype
7%
Humoral Immune Response
5%
Pharmacology, Toxicology and Pharmaceutical Science
Enterovirus
50%
Vaccine Development
11%
Poliomyelitis Virus
11%
Clinical Trial
7%
